Pure Global AI
NCT06402357Not yet recruiting

High Intensity Focused Ultrasound in Prostate Cancer

Salvage Focal Therapy Via High Intensity Focused Ultrasound (HIFU) in Radiorecurrent Localized Prostate Cancer
University of FloridaPhase 2ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Prostate Cancer
Drug/Device/Intervention
Focal One high intensity focused ultrasound device
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Florida
Location
Gainesville, United States of America
Timeline & enrollment
Phase
Phase 2
Start date
Aug 01, 2024
End date
Aug 01, 2029
Enrollment
25 participants
Primary outcome

In-field failure-free survival

Summary

This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in
 patients with localized radiorecurrent prostate cancer. This study will also investigate the
 change in participant quality of life after HIFU therapy as compared to before HIFU therapy.

ICD-10 classifications
Malignant neoplasm of prostateHyperplasia of prostateDisorder of prostate, unspecifiedOther disorders of prostateCarcinoma in situ: Prostate
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06402357
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06402357 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Florida and is currently Not yet recruiting. The study focuses on Prostate Cancer. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.